2021
DOI: 10.1016/j.ijporl.2021.110743
|View full text |Cite
|
Sign up to set email alerts
|

In vitro study on immune response modifiers as novel medical treatment options for cholesteatoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 58 publications
0
2
0
Order By: Relevance
“…The main anti-inflammatory cytokine, Interleukin-10 (IL-10), on the other hand, works against high pro-inflammatory cytokine levels in cholesteatoma tissue [17,18]. An imbalance of IL-1 and IL-10 is believed to cause an uncontrolled inflammatory process, which is destructive for the surrounding bone in the middle ear [20].…”
Section: Introductionmentioning
confidence: 99%
“…The main anti-inflammatory cytokine, Interleukin-10 (IL-10), on the other hand, works against high pro-inflammatory cytokine levels in cholesteatoma tissue [17,18]. An imbalance of IL-1 and IL-10 is believed to cause an uncontrolled inflammatory process, which is destructive for the surrounding bone in the middle ear [20].…”
Section: Introductionmentioning
confidence: 99%
“…By contrast, interleukin 10 is the most active anti-inflammatory cytokine, and its impaired expression can exacerbate the inflammatory response and lead to tissue damage [ 21 ]. The disproportion between IL-1 and IL-10 in cholesteatoma could be one of many causes of its aggressiveness [ 22 ]. Furthermore, human beta defensins 2 and 4 reduce the inflammation caused selectively by Ps.…”
Section: Introductionmentioning
confidence: 99%